To view the PDF file, sign up for a MySharenet subscription.

DISCOVERY LIMITED - Discovery-Availability of Guarantor AFS

Release Date: 24/10/2025 07:30
Code(s): DSY09 DSY08 DSYC02 DSY06 DSY07 DSY04 DSYC01     PDF:  
Wrap Text
Discovery-Availability of Guarantor AFS

 Discovery Limited
 (Incorporated in the Republic of South Africa)
 (Registration No. 1999/007789/06)
 Legal Entity Identifier: 378900245A26169C8132
 Company code: DSYI
 ("Discovery" or the "Issuer")


 AVAILABILITY OF THE GUARANTORS' ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

 In accordance with paragraph 6.5 and 6.7 of the JSE Limited Debt and Specialist Securities Listings Requirements,
 noteholders are advised that the audited annual financial statements ("AFS") of Discovery Vitality
 Proprietary Limited ("Discovery Vitality") and Discovery Health Proprietary Limited ("Discovery Health")
 (collectively, the "Guarantors") for the year ended 30 June 2025 (the "financial statements") are available on the
 Issuer's website at www.discovery.co.za/corporate/additional-material

 Noteholders are advised that the audit reports on the Guarantors' financial statements were unqualified, with
 no modifications applicable.

 Noteholders are advised that corrections and restatements were made to the Guarantors' previously published
 financial statements included in the AFS for the year ended 30 June 2025. These corrections and restatements,
 summarised below, did not affect the reported profit for the prior period.

 A summary of the details of these corrections and restatements is provided below. Additional information
 regarding these changes have been disclosed within the financial statements of the Guarantors, as referenced
 below.

 As outlined in Note 23 of the audited AFS of Discovery Vitality, the following restatements were made:
 • Correction of prior period errors in the Statement of Comprehensive Income. The correction related to the
     presentation of specified income items, which were reclassified as either Revenue or as a reduction in Benefit
     expense. This adjustment did not affect the reported profit for the prior period, the Statement of Financial
     Position, or the Statement of Cash Flows.
 • Changes in the presentation of specified items within the Statement of Financial Position, where specific line
     items were either disaggregated, aggregated or reclassified to enhance the clarity and understandability of
     the financial information. These adjustments did not affect the reported profit for the prior period or the
     Statement of Cash Flows.

 As outlined in Note 5.6 of the audited AFS of Discovery Health, the following restatements were made:
 • Changes in the presentation of specified items within the Statement of Financial Position, where specific line
     items were disaggregated, aggregated, or reclassified to enhance the clarity and understandability of the
     financial information. These adjustments did not affect the reported profit for the prior period or the
     Statement of Cash Flows.



 Sandton
 23 October 2025


Equity and Debt Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Date: 24-10-2025 07:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.